Julian Wichmann

Modality.ai provides multimodal technology for the objective assessment of CNS conditions through automated speech and visual analytics of conversations elicited by Tina, a virtual guide. Our platform is used in clinic and remotely in IRB approved studies generating over 20,000 recorded sessions to date. Modality is led by a team of world-class scientists, clinicians, technologists, and serial entrepreneurs, and has shown clinical validation through numerous peer-reviewed publications.

Segmed provides at-scale access to novel clinical data globally, offering millions of diagnostic-grade medical images to accelerate innovation and mature the evidence needs of life sciences and technology industry. ‍ Our solutions allow you to access a RWD network to facilitate rapid discovery and investigational capability of imaging data, development of early disease detection & prediction models, improved patient recruitment and reduced operating burden to access therapeutic data ecosystem.

Our purpose is to redefine the cannabis industry and craft a new episode in its history. Our vision is to become the No 1. brand ecosphere in the recreational cannabis sector. We are convinced that it’s time to switch lanes & move cannabis beyond its sole purpose as an ailment-relief treatment for patients. We believe in cannabis as a statement by people who dare to tap into themselves & live an elevated, modern and community-driven life.

Bloomwell is the app for medical cannabis. The all-round solution for modern cannabis therapy. 👉 Online consultations 👉 Direct price comparison and fast delivery 👉 Everything 100% digital, discreet and fast

Modality.ai provides multimodal technology for the objective assessment of CNS conditions through automated speech and visual analytics of conversations elicited by Tina, a virtual guide. Our platform is used in clinic and remotely in IRB approved studies generating over 20,000 recorded sessions to date. Modality is led by a team of world-class scientists, clinicians, technologists, and serial entrepreneurs, and has shown clinical validation through numerous peer-reviewed publications.

Segmed provides at-scale access to novel clinical data globally, offering millions of diagnostic-grade medical images to accelerate innovation and mature the evidence needs of life sciences and technology industry. ‍ Our solutions allow you to access a RWD network to facilitate rapid discovery and investigational capability of imaging data, development of early disease detection & prediction models, improved patient recruitment and reduced operating burden to access therapeutic data ecosystem.